Valeant Pharmaceuticals reported $799M in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Amgen AMGN:US $ 3228M 40M
Ani Pharmaceuticals ANIP:US $ 8.01M 3.32M
Aphria Inc APH:CN C$ -69699000 38.32M
Aurora Cannabis Inc ACB:CN -25958000 65.4M
Biogen BIIB:US $ 991.8M 155.8M
Bristol Myers Squibb BMY:US $ 5712M 33M
Canopy Growth Corp WEED:CN C$ -184069000 116.52M
Catalent CTLT:US $ 222M 104.3M
Corcept Therapeutics CORT:US $ 36.5M 4.3M
Danaher DHR:US $ 1863M 667M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Endo International Ordinary Shares ENDP:US $ 320.03M 5.28M
Gilead Sciences GILD:US $ 4370M 1605M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Horizon Pharma HZNP:US $ 439.93M 134.24M
JAZZ PHA JAZZ:US $ 195.95M 118.22M
Lannett LCI:US $ -4.15M 8.72M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Pacira Pharmaceuticals PCRX:US $ 36.49M 3.4M
Perrigo Ordinary Shares PRGO:US $ 527.9M 408.9M
Phibro Animal Health PAHC:US $ 22.47M 4.54M
Prestige Brands PBH:US $ 86.52M 12.42M
Revance Therapeutics RVNC:US $ -67.57M 2.28M
Supernus Pharmaceuticals SUPN:US $ 38.61M 2.15M
Valeant Pharmaceuticals VRX:CN $ 799M 67M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
Zoetis ZTS:US $ 845M 7M